Theravance Biopharma, Inc. (TBPH)

Last Closing Price: 9.16 (2025-05-30)

Combined Ratio (Quarterly)

Combined Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The combined ratio is calculated by taking the sum of incurred losses and expenses and then dividing them by earned premium. Calculated as: Total Operating Expenses / Net Premiums Earned

Theravance Biopharma, Inc. (TBPH) Combined Ratio data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$15.39M
$-13.58M
--
$15.39M
$29.82M
$-14.43M
$0.30M
$-14.14M
$-14.14M
$-13.58M
$-13.58M
$-13.58M
$-13.58M
$-14.43M
$-14.35M
49.71M
49.71M
$-0.27
$-0.27
Balance Sheet Financials
$150.26M
$7.03M
$193.32M
$343.58M
$31.50M
--
$146.10M
$177.60M
$165.98M
$165.98M
$165.98M
50.00M
Cash Flow Statement Financials
$43.04M
$30.63M
$-0.85M
$38.63M
$111.45M
$72.82M
$4.88M
--
--
Fundamental Metrics & Ratios
4.77
--
--
--
--
100.00%
-93.80%
-93.80%
--
-91.88%
-88.24%
$43.04M
--
--
Combined Ratio
--
0.04
--
1.00
89.80
-8.18%
-8.18%
-3.95%
-8.18%
$3.32
$0.87
$0.87